Gombach leans on practices she learned in acceptance and commitment therapy, which focuses on aligning behavior with one's values
At week 20, bodyweight reductions were observed to be greater with cagrilintide 1.2 and 2.4 mg than with placebo (15.7% for cagrilintide 1.2 mg and 17.1% for cagrilintide 2.4 mg vs
The September 2024 LIFT-AD trial termination after meeting enrollment demonstrates that this approach, despite decades of development, does not slow Alzheimer's cognitive decline in humans
"Everyone ages and declines eventually, but there are ways that you can age gracefully, and GLP-1s are a way to have a smoother transition" for older adults who meet the criteria for the medications, he says
Hormonal monitoring and interventions, such as scheduling high-risk training activities during phases of lower estrogen levels, could be considered to mitigate this risk
What happens if I overdose